F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: hepatic encephalopathy

Page 1 of 3 ( 106 items )
<<
1
2
3
>>

1	Modified model incorporating sarcopenia and myosteatosis for predicting severe hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: Multicenter study 7/17/2026 8:23:30 AM \| Browse: 44 \| Download: 101
2	Letter to the Editor: Beyond the liver - integrating emerging predictors in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 6/25/2026 6:40:07 AM \| Browse: 29 \| Download: 102
3	Differentiation of minimal and grade 1 hepatic encephalopathy using neurophysiological, neuropsychological, magnetic resonance spectroscopic, and systemic inflammatory parameters 5/26/2026 3:52:10 AM \| Browse: 28 \| Download: 313
4	Multidimensional cognitive impairment in hepatosplenic schistosomiasis: A cross-sectional study 3/30/2026 8:58:25 AM \| Browse: 93 \| Download: 392
5	Role of cerebral blood flow changes in post-transjugular intrahepatic portosystemic shunts hepatic encephalopathy 2/25/2026 5:32:44 AM \| Browse: 66 \| Download: 386
6	Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification 2/12/2026 11:20:20 AM \| Browse: 116 \| Download: 501
7	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 135 \| Download: 505
8	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 165 \| Download: 497
9	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 153 \| Download: 393
10	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 228 \| Download: 476
11	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 395 \| Download: 786
12	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 339 \| Download: 494
13	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 286 \| Download: 725
14	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 522 \| Download: 697
15	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 368 \| Download: 369
16	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 283 \| Download: 613
17	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 141 \| Download: 383
18	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 163 \| Download: 1034
19	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 175 \| Download: 988
20	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 136 \| Download: 374
21	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 181 \| Download: 740
22	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 353 \| Download: 816
23	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 263 \| Download: 1038
24	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 148 \| Download: 931
25	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 218 \| Download: 616
26	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 270 \| Download: 711
27	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 188 \| Download: 950
28	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 220 \| Download: 943
29	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 219 \| Download: 776
30	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 314 \| Download: 805
31	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 328 \| Download: 886
32	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 239 \| Download: 899
33	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 306 \| Download: 1286
34	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 290 \| Download: 1286
35	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 196 \| Download: 830
36	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 417 \| Download: 1189
37	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 440 \| Download: 1168
38	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 493 \| Download: 1408
39	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 441 \| Download: 1152
40	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 415 \| Download: 995
41	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 479 \| Download: 1070
42	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 564 \| Download: 1808
43	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 668 \| Download: 1484
44	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 699 \| Download: 1667
45	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 780 \| Download: 1639
46	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 759 \| Download: 1448
47	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 896 \| Download: 2616
48	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 767 \| Download: 2620
49	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 762 \| Download: 1750
50	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 731 \| Download: 1263

Page 1 of 3 ( 106 items )
<<
1
2
3
>>

1	Modified model incorporating sarcopenia and myosteatosis for predicting severe hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: Multicenter study 7/17/2026 8:23:30 AM \| Browse: 44 \| Download: 101
2	Letter to the Editor: Beyond the liver - integrating emerging predictors in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 6/25/2026 6:40:07 AM \| Browse: 29 \| Download: 102
3	Differentiation of minimal and grade 1 hepatic encephalopathy using neurophysiological, neuropsychological, magnetic resonance spectroscopic, and systemic inflammatory parameters 5/26/2026 3:52:10 AM \| Browse: 28 \| Download: 313
4	Multidimensional cognitive impairment in hepatosplenic schistosomiasis: A cross-sectional study 3/30/2026 8:58:25 AM \| Browse: 93 \| Download: 392
5	Role of cerebral blood flow changes in post-transjugular intrahepatic portosystemic shunts hepatic encephalopathy 2/25/2026 5:32:44 AM \| Browse: 66 \| Download: 386
6	Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification 2/12/2026 11:20:20 AM \| Browse: 116 \| Download: 501
7	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 135 \| Download: 505
8	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 165 \| Download: 497
9	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 153 \| Download: 393
10	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 228 \| Download: 476
11	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 395 \| Download: 786
12	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 339 \| Download: 494
13	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 286 \| Download: 725
14	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 522 \| Download: 697
15	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 368 \| Download: 369
16	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 283 \| Download: 613
17	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 141 \| Download: 383
18	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 163 \| Download: 1034
19	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 175 \| Download: 988
20	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 136 \| Download: 374
21	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 181 \| Download: 740
22	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 353 \| Download: 816
23	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 263 \| Download: 1038
24	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 148 \| Download: 931
25	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 218 \| Download: 616
26	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 270 \| Download: 711
27	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 188 \| Download: 950
28	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 220 \| Download: 943
29	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 219 \| Download: 776
30	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 314 \| Download: 805
31	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 328 \| Download: 886
32	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 239 \| Download: 899
33	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 306 \| Download: 1286
34	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 290 \| Download: 1286
35	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 196 \| Download: 830
36	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 417 \| Download: 1189
37	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 440 \| Download: 1168
38	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 493 \| Download: 1408
39	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 441 \| Download: 1152
40	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 415 \| Download: 995
41	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 479 \| Download: 1070
42	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 564 \| Download: 1808
43	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 668 \| Download: 1484
44	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 699 \| Download: 1667
45	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 780 \| Download: 1639
46	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 759 \| Download: 1448
47	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 896 \| Download: 2616
48	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 767 \| Download: 2620
49	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 762 \| Download: 1750
50	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 731 \| Download: 1263